Breaking News
Get 50% Off 0
🏦📉 What the Fed Rate decision means for global markets
Ask WarrenAI
Close

Moderna Inc (MRNA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Moderna's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
154.04 -4.03    -2.55%
15:59:59 - Closed. Currency in USD
After Hours
153.90
-0.14
-0.09%
19:59:27 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 20,238,545
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 150.26 - 159.79
Moderna 154.04 -4.03 -2.55%

Moderna Option Chain

 
View the MRNA options chain and compare options of Moderna stock. Analyze the various options available, including call options (the right to buy) and put options (the right to sell), along with their strike prices and expiration dates. Evaluate the prices and premiums associated with these options to make informed decisions about your trading strategies. Assess the Open Positions chart to find information about the distribution of open options contracts for MRNA stock at various strike prices and expiration dates. Gain insights into the options market sentiment and the potential trading activity surrounding the Moderna stock.
Expiration Date:
Show:
Strike Price:
Sep 18, 2026 08:14PM GMT

Calls

Puts

Last Chg. Bid Ask Vol Strike Last Chg. Bid Ask Vol
0 0% 113.15 117.05 0 40.00 0 0% 0 0.2 0
0 0% 110.2 114.2 0 43.00 0.02 0% 0 2.13 0
0 0% 109.2 113.2 0 44.00 0.02 0% 0 0.01 94
154.04
Price @ Sep 18, 2026 08:14PM GMT
5.98 -28.72% 5.8 5.95 343 155.00 5.73 -6.83% 5.55 5.75 445
4.8 -36% 4.75 4.95 6,758 157.50 6.99 -2.24% 7.05 7.2 168
4 -34.43% 3.8 4.05 2,199 160.00 9.18 9.94% 8.55 8.8 258

Open Positions

 Calls
 Puts
© 2016 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRNA Comments

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Neil Young
Neil Young Sep 17, 2026 10:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$160.60 (+10%)
Joe Jordan
Joe Jordan Sep 17, 2026 2:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big opportunity for Merck to buy Moderna at 215 USD?
Mr BullBear
Mr BullBear Sep 15, 2026 8:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Today red
Joe Jordan
Joe Jordan Sep 14, 2026 10:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Moderna’s oncology pipeline looks highly promising, especially its personalized mRNA cancer vaccine intismeran autogene combined with Merck’s Keytruda. In a Phase 3 melanoma trial, the combination significantly improved recurrence-free and distant-metastasis-free survival versus Keytruda alone, potentially establishing a new personalized-treatment model. The opportunity could extend to lung, bladder, kidney, pancreatic and stomach cancers, where further trials are ongoing. However, the results are not yet equivalent to a proven overall-survival benefit, and regulatory approval, manufacturing complexity and broader trial confirmation remain important
Neil Young
Neil Young Sep 11, 2026 12:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$147.55 (+8%)
Shah King
Shah King Aug 28, 2026 2:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when they offer 2 billion notes, what else can it do apart from diluting the stock ?
Russell Crowe
Maximus_Meridius Aug 25, 2026 1:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A technology that has proven itself to deliver in crisis and now focused on cancer with FDA approval should not be dismissed. Especially in the hottest sector of the economy... Biotech is the new AI trade !
Mr BullBear
Mr BullBear Aug 25, 2026 6:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
WOW
Mr BullBear
Mr BullBear Aug 25, 2026 6:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well well well no ody wants ro buy moderna
Mr BullBear
Mr BullBear Aug 25, 2026 6:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pre market is going RED
 
Are you sure you want to delete this chart?
 
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email